Legend Biotech Corporation
LEGN
$27.75
$1.063.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.15% | -14.15% | 53.18% | 65.84% | 31.65% |
| Total Depreciation and Amortization | 18.23% | 4.31% | 5.74% | 16.35% | 10.21% |
| Total Amortization of Deferred Charges | -54.63% | -78.38% | -80.75% | -89.14% | -80.24% |
| Total Other Non-Cash Items | 58.10% | 596.33% | -21.13% | -83.08% | -20.24% |
| Change in Net Operating Assets | -376.91% | -366.62% | -441.24% | 73.99% | 788.38% |
| Cash from Operations | -7.91% | -92.60% | -10.38% | 63.38% | 54.63% |
| Capital Expenditure | -15.79% | 19.17% | 55.28% | 29.77% | 27.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.55% | 139.82% | 36.80% | -841.06% | -26.77% |
| Cash from Investing | 95.29% | 137.20% | 38.08% | -1,016.67% | -22.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -28.80% | -24.14% | -9.14% | -7.00% | 49.18% |
| Issuance of Common Stock | -63.10% | 10.30% | -98.80% | -98.78% | -98.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.80% | -2.26% | -99.30% | -99.28% | -99.12% |
| Foreign Exchange rate Adjustments | 289.48% | 1,117.26% | -112.70% | -405.72% | 187.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 64.22% | 106.33% | -291.93% | -301.55% | -434.49% |